Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)
Sponsor: Shionogi
Summary
The primary purpose of this study is to evaluate the long-term safety and tolerability profile of S-606001 in participants with LOPD. Participants who completed other S-606001 studies (for example, NCT07123155), including participants in a S-606001 study whose allocated arm was terminated by the sponsor and who are willing to participate in this study, will be enrolled globally.
Official title: A Phase 2, Open-label, Multicenter, Extension Study to Investigate the Long-term Safety and Efficacy of S-606001 in Patients With Late-onset Pompe Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-08-31
Completion Date
2028-08-31
Last Updated
2026-08-06
Healthy Volunteers
No
Conditions
Interventions
S-606001
S-606001 will be administered orally.
ERT
ERT will be administered as an intravenous infusion.